STIFEL FINANCIAL CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$25,637,900
+3.2%
251,681
+2.2%
0.04%
+5.9%
Q2 2023$24,847,030
+1.3%
246,213
-7.6%
0.03%
-2.9%
Q1 2023$24,524,785
+4.1%
266,559
+2.7%
0.04%0.0%
Q4 2022$23,555,378
+8.8%
259,632
-8.8%
0.04%0.0%
Q3 2022$21,647,000
-29.2%
284,771
-21.3%
0.04%
-27.1%
Q2 2022$30,596,000
-6.8%
361,916
-3.3%
0.05%
+6.7%
Q1 2022$32,845,000
+8.6%
374,265
+8.3%
0.04%
+12.5%
Q4 2021$30,239,000
+1.8%
345,691
-4.8%
0.04%
-9.1%
Q3 2021$29,695,000
-0.6%
363,083
+10.9%
0.04%
-2.2%
Q2 2021$29,872,000
+4.6%
327,372
-2.0%
0.04%
-4.3%
Q1 2021$28,560,000
-24.1%
334,108
-16.1%
0.05%
-29.9%
Q4 2020$37,619,000
+8.7%
398,379
+0.1%
0.07%
-5.6%
Q3 2020$34,613,000
+2.2%
398,041
+2.6%
0.07%
-9.0%
Q2 2020$33,868,000
-1.3%
387,789
-7.1%
0.08%
-17.9%
Q1 2020$34,309,000
-23.0%
417,349
-11.4%
0.10%
+2.2%
Q4 2019$44,570,000
+33.5%
470,950
+22.6%
0.09%
+9.4%
Q3 2019$33,394,000
-19.2%
384,084
-15.3%
0.08%
-20.6%
Q2 2019$41,335,000
+17.5%
453,292
+23.8%
0.11%
+8.1%
Q1 2019$35,176,000
+10.7%
366,104
-1.2%
0.10%
-3.9%
Q4 2018$31,785,000
+23.5%
370,503
+24.1%
0.10%
+39.2%
Q3 2018$25,733,000
+12.0%
298,569
-1.7%
0.07%
+4.2%
Q2 2018$22,982,000
+1.4%
303,657
+8.2%
0.07%
-1.4%
Q1 2018$22,657,000
-2.2%
280,631
+1.6%
0.07%
-1.4%
Q4 2017$23,160,000
-0.3%
276,270
+2.2%
0.07%
-9.9%
Q3 2017$23,225,000
+8.7%
270,251
+5.7%
0.08%
+2.5%
Q2 2017$21,367,000
-4.3%
255,622
-15.1%
0.08%
-8.1%
Q1 2017$22,323,000
+9.1%
301,260
+7.2%
0.09%
-1.1%
Q4 2016$20,470,000
+11.4%
281,003
+20.9%
0.09%
+4.8%
Q3 2016$18,379,000
-13.8%
232,391
-10.0%
0.08%
-16.2%
Q2 2016$21,312,000
+21.1%
258,271
+6.3%
0.10%
+5.3%
Q1 2016$17,596,000
-20.0%
242,912
-5.0%
0.09%
-18.3%
Q4 2015$22,002,000
-0.2%
255,739
+6.6%
0.12%
-7.3%
Q3 2015$22,051,000
-51.5%
239,945
-48.4%
0.12%
+4.2%
Q2 2015$45,506,000
+95.7%
464,750
+97.0%
0.12%
-6.3%
Q1 2015$23,252,000
+9.2%
235,916
+2.7%
0.13%
+7.6%
Q4 2014$21,291,000
+41.6%
229,670
+43.8%
0.12%
-10.6%
Q3 2014$15,033,000
+20.0%
159,705
+15.4%
0.13%
+16.8%
Q2 2014$12,528,000
+5.0%
138,382
-1.4%
0.11%
-0.9%
Q1 2014$11,926,000140,2790.11%
Other shareholders
NOVARTIS A G shareholders Q3 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders